References:
1. Merriel A, Maharjan N, Clayton G, Toolan M, Lynch M, Barnard K, et al. A cross-sectional study to evaluate antenatal care service provision in 3 hospitals in Nepal. AJOG Glob Rep. 2021 Aug 1;1(3):100015. 2. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map. PLOS Med. 2012 Nov 13;9(11):e1001339. 3. WHO Guidelines for malaria - 3 June 2022. 2022; 4. Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014 Nov 3;13(1):418. 5. Yilma D, Groves ES, Brito-Sousa JD, Monteiro WM, Chu C, Thriemer K, et al. Severe Hemolysis during Primaquine Radical Cure of Plasmodium vivax Malaria: Two Systematic Reviews and Individual Patient Data Descriptive Analyses. 2023 Oct 4 [cited 2024 Aug 8]; Available from: https://www.ajtmh.org/view/journals/tpmd/109/4/article-p761.xml6. Watson J, Taylor WR, Menard D, Kheng S, White NJ. Modelling primaquine-induced haemolysis in G6PD deficiency. eLife. 6:e23061. 7. Brito MAM, Peixoto HM, Almeida ACG de, Oliveira MRF de, Romero GAS, Moura-Neto JP, et al. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon. Rev Soc Bras Med Trop. 2016 Aug;49:446–55. 8. Brito-Sousa JD, Santos TC, Avalos S, Fontecha G, Melo GC, Val F, et al. Clinical Spectrum of Primaquine-induced Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficiency: A 9-Year Hospitalization-based Study From the Brazilian Amazon. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019 Sep 27;69(8):1440–2. 9. Satyagraha AW, Sadhewa A, Elvira R, Elyazar I, Feriandika D, Antonjaya U, et al. Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia. PLoS Negl Trop Dis. 2016 Feb 19;10(2):e0004457. 10. Epidemiology and Disease, Control Division, Department of Health Services (2019). National Malaria Treatment Protocol 2019. 11. Commons RJ, Simpson JA, Thriemer K, Chu CS, Douglas NM, Abreha T, et al. The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis. BMC Med. 2019 Aug 1;17(1):151. 12. Kosasih A, James R, Chau NH, Karman MM, Panggalo LV, Wini L, et al. Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials with G6PD Screening. Pathogens. 2023 Sep;12(9):1176. 13. Pal S, Bansil P, Bancone G, Hrutkay S, Kahn M, Gornsawun G, et al. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient. Am J Trop Med Hyg. 2019 Jan;100(1):213–21. 14. Ley B, Thriemer K, Jaswal J, Poirot E, Alam MS, Phru CS, et al. Barriers to routine G6PD testing prior to treatment with primaquine. Malar J. 2017 Aug 10;16(1):329.